<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:33:47Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16958" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16958</identifier><datestamp>2026-10-18T20:41:10Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Diagnostic Value of Adenosine Deaminase Level for the Differential Diagnosis of Tuberculosis and Malignancy in Exudative Lymphocytic Pleurisy</dc:title><dc:creator>Altinsoy, Bulent</dc:creator><dc:creator>Yalcinsoy, Murat</dc:creator><dc:creator>Unver, Edhem</dc:creator><dc:creator>Gungor, Sinem</dc:creator><dc:creator>Mihmanli, Aydanur</dc:creator><dc:creator>Akkaya, Esen</dc:creator><dc:subject>Adenosine deaminase</dc:subject><dc:subject>malignancy</dc:subject><dc:subject>tuberculosis</dc:subject><dc:subject>pleurisy</dc:subject><dc:subject>PREDICTIVE MODELS</dc:subject><dc:subject>EFFUSIONS</dc:subject><dc:subject>FLUID</dc:subject><dc:subject>CANCER</dc:subject><dc:subject>Medicine, General &amp; Internal</dc:subject><dc:subject>General &amp; Internal Medicine</dc:subject><dc:description>Objective: To evaluate the diagnostic performance of adenosine deaminase (ADA) levels in patients with exudative lymphocytic pleurisy for the differential diagnosis of tuberculous pleurisy (TBP) and malignant pleural effusion (MPE). Methods: Data on patients with exudative lymphocytic pleurisy were retrospectively analyzed. The study population comprised 54 patients. Thirty-seven were diagnosed with TBP and 17 were diagnosed with MPE. Results: Significant differences were determined in terms of age and ADA, total protein, albumin, and LDH levels between the TBP and MPE groups. The optimal cut-off value of ADA levels was 35.1 U/L for diagnosing TBP. Sensitivity and specificity were 92% and 100%, respectively. Logistic regression analysis was performed to assess independent variables associated with TBP. Independent predictive factors in the model were ADA (OR: 1.21, 95% CI: 1.06-1.39, p=0.006)], and (OR: 0.92, 95% CI: 0.84-1.00, p=0.052)]. The AUC value by the regression equation was 0.979 (p&lt;0.001). When patients were categorized according to age (&lt;50 ve &gt;= 50), two different cut-off values (&gt; 13.51 and &gt; 35.1) for each age range were found in all, but one, TBP patients. Conclusion: ADA levels are useful for the diagnosis of TBP in cases where pleural biopsy cannot be performed or that are inconclusive in making a diagnosis of TBP. In this group, reducing the conventional cut-off value and/or performing an age-based approach seems to improve the diagnostic performance of ADA levels.</dc:description><dc:publisher>AVES</dc:publisher><dc:date>2016</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/16958</dc:identifier><dc:identifier>https://doi.org/10.5152/imj.2016.34735</dc:identifier><dc:identifier>1304-8503</dc:identifier><dc:language>tr</dc:language><dc:relation>ISTANBUL MEDICAL JOURNAL</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16958</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>